Dashboard
Manage Tickers

LASRNLIGHT, INC.

Nasdaq nlight.net


$ 13.27 $ 0.17 (1.3 %)    

Wednesday, 15-May-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 13.27
$ 13.19
$ 0.00 x 0
$ 0.00 x 0
$ 13.19 - $ 13.39
$ 8.13 - $ 15.91
138,592
na
626.9M
$ 2.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-09-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-25-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benchmark-reiterates-speculative-buy-on-nlight-maintains-17-price-target
Benchmark Reiterates Speculative Buy on nL...
05/03/2024 17:28:52

Benchmark analyst Mark Miller reiterates nLight (NASDAQ:LASR) with a Speculative Buy and maintains $17 price target.

needham-maintains-buy-on-nlight-lowers-price-target-to-15
Needham Maintains Buy on nLight, Lowers Pr...
05/03/2024 11:45:09

Needham analyst James Ricchiuti maintains nLight (NASDAQ:LASR) with a Buy and lowers the price target from $16 to $15.

nlight-sees-q2-2204-revenue-47m-451m-vs-48165m-est
nLIGHT Sees Q2 2204 Revenue $47M-4$51M Vs ...
05/02/2024 21:41:29

nlight-q1-2024-adj-eps-017-beats-019-estimate-sales-44527m-beat-44269m-estimate
nLight Q1 2024 Adj EPS $(0.17) Beats $(0.1...
05/02/2024 20:36:20

nLight (NASDAQ:LASR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10....

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

nlight-sees-q1-2024-revenue-42m-6m-vs-50714m-est
nLIGHT Sees Q1 2024 Revenue $42M-$6M Vs $5...
02/22/2024 21:57:03

nlight-q4-earnings-insights
nLight: Q4 Earnings Insights
02/22/2024 21:20:08

nlight-q4-2023-adj-eps-013-beats-014-estimate-sales-5189m-beat-4799m-estimate
nLight Q4 2023 Adj EPS $(0.13) Beats $(0.1...
02/22/2024 21:20:02

nLight (NASDAQ:LASR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.1...

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

why-nlight-stock-lasr-is-rising-during-tuesdays-session
Why nLIGHT Stock (LASR) Is Rising During T...
11/28/2023 20:17:04

nLIGHT Inc (NASDAQ: LASR) shares are trading higher by 2.8% to $13.32 Tuesday afternoon after Benchmark upgraded the stock from...

needham-maintains-buy-rating-for-nlight-heres-what-you-need-to-know
Needham Maintains Buy Rating for nLight: H...
11/28/2023 17:00:21

pdd-posts-upbeat-revenue-joins-avidity-biosciences-springworks-therapeutics-and-other-big-stocks-moving-higher-on-tuesday
PDD Posts Upbeat Revenue, Joins Avidity Bi...
11/28/2023 14:39:07

U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday.

boeing-to-rally-more-than-25-here-are-10-top-analyst-forecasts-for-tuesday
Boeing To Rally More Than 25%? Here Are 10...
11/28/2023 13:09:51

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

benchmark-upgrades-nlight-to-speculative-buy-announces-17-price-target
Benchmark Upgrades nLight to Speculative B...
11/28/2023 11:52:20

Benchmark analyst Mark Miller upgrades nLight (NASDAQ:LASR) from Hold to Speculative Buy and announces $17 price target.

needham-maintains-buy-on-nlight-raises-price-target-to-16
Needham Maintains Buy on nLight, Raises Pr...
11/28/2023 11:31:07

Needham analyst James Ricchiuti maintains nLight (NASDAQ:LASR) with a Buy and raises the price target from $15 to $16.

why-nlight-stock-lasr-is-trading-higher-monday
Why nLight Stock (LASR) Is Trading Higher ...
11/27/2023 16:09:17

nLIGHT Inc (NASDAQ: LASR) shares are trading higher by 8.7% to $12.38 Monday morning after the company announced a $34.5 millio...

nlight-announces-345m-contract-for-de-m-shorad-laser-weapon-system
nLIGHT Announces $34.5M Contract For DE M-...
11/27/2023 12:05:07

nlight-announces-expansion-of-helsi-contract-award-to-171m-for-development-of-1-megawatt-directed-energy-laser
nLIGHT Announces Expansion Of HELSI Contra...
11/02/2023 21:09:27

nLIGHT to deliver 1 Megawatt-class laser over three-year programnLIGHT, Inc. (NASDAQ:LASR), a leading provider of high-power se...

nlight-q3-adj-eps-010-misses-008-estimate-sales-5063m-beat-4929m-estimate
nLight Q3 Adj EPS $(0.10) Misses $(0.08) E...
11/02/2023 20:20:14

nLight (NASDAQ:LASR) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.08) by 2...

earnings-scheduled-for-november-2-2023
Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION